🟢 Edesa Biotech is trading 5.8% up today on technical rebound following recent sharp declines

Edesa Biotech is trading at $5.26 (up 5.8%), staging a recovery after several sharp declines over the past week.

• The move appears to be a technical correction following a 7.1% after-hours rebound on July 28, with no clear fundamental news driving the price action.
• The stock is outperforming the broader biotech and equity markets, which are currently weaker, suggesting a company-specific price recovery rather than a macro-driven rally.